
Quanterix Announces Landmark Nature Study Redefining Alzheimer’S Disease Neuropathology Prevalence
Dec 22 (Reuters) - Quanterix Corp (QTRX.O) :
* QUANTERIX ANNOUNCES LANDMARK NATURE STUDY REDEFINING ALZHEIMER’S DISEASE NEUROPATHOLOGY PREVALENCE Source text: Further company coverage: (QTRX.O)